Praxis Precision Medicines, Inc. (PRAX)
NASDAQ: PRAX · IEX Real-Time Price · USD
56.26
+1.30 (2.37%)
Jul 22, 2024, 12:23 PM EDT - Market open
PRAX Employees
Praxis Precision Medicines had 82 employees as of December 31, 2023. The number of employees decreased by 27 or -24.77% compared to the previous year.
Employees
82
Change (1Y)
-27
Growth (1Y)
-24.77%
Revenue / Employee
$26,768
Profits / Employee
-$1,528,963
Market Cap
942.56M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 82 | -27 | -24.77% |
Dec 31, 2022 | 109 | -30 | -21.58% |
Dec 31, 2021 | 139 | 72 | 107.46% |
Dec 31, 2020 | 67 | - | - |
Related Stocks
Company Name | Employees |
---|---|
HealthStream | 1,092 |
Pacira BioSciences | 712 |
CareDx | 643 |
BioLife Solutions | 414 |
Cronos Group | 356 |
Bicycle Therapeutics | 284 |
AnaptysBio | 117 |
Silence Therapeutics | 109 |
PRAX News
- 6 weeks ago - Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - Praxis Precision Medicines to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2024 Financial Results - GlobeNewsWire
- 2 months ago - Praxis Precision Medicines to Report First Quarter 2024 Financial Results on Monday, May 13, 2024 - GlobeNewsWire
- 3 months ago - Praxis Precision Medicines to Present on Ulixacaltamide at the American Academy of Neurology 2024 Annual Meeting - GlobeNewsWire
- 3 months ago - Praxis Precision Medicines to Participate in Upcoming April Conferences - GlobeNewsWire
- 4 months ago - Praxis Precision Medicines, Inc. Announces Pricing of $200 Million Public Offering - GlobeNewsWire
- 4 months ago - Praxis Precision Medicines, Inc. Announces Proposed Public Offering - GlobeNewsWire